GHP December 2016

GHP December 2016

Welcome to the December issue of GHP Magazine.
As 2016 rolls into its closing stretches, this issue looks back with pride on the past year on the milestones that have been reached, the innovations achieved, the lives saved, through the vigilant work of thousands upon thousands of companies and institutions, comprising countless individuals, as they battle to overcome the challenges of their respective markets to ensure affordable and reliable healthcare for all.

To begin with, GHP pays particular notice to the technological breakthroughs and developments of recent months; the application of new child-proof safety containers and bio-friendly plastic films, made from all-new low-gauge materials, spell out a secure and safe future not only for Locked4Kids and PolyPak America, but for the millions of consumers that utilise these products every day. The potential to avert mishaps and even deaths is an opportunity that should be embraced readily, well into the future.

It is not only the applications and development of human medicine that GHP pays close attention to – the world of veterinary care is also a crucial area of focus, and this issue pays attention to the selfless services of such institutions dedicated to animal care as the Sierra Lione Animal Welfare Society, whose mission to curtail rabies in the West of Africa has drawn international attention and encouraged a greater awareness for the contagious disease.

Indeed, funding and investment continues to remain a central component of the ongoing development of the healthcare and pharmaceutical industries. While the Northamptonshire charity Animals in Need relies upon the donations of food, toys and bedding as well as finances from the public to support over 600 animals, there is an observable effort across all markets to capitalise upon an age of advanced medicine to develop new approaches to maintaining a consistent level of care for all those that require it. This is also why technological innovations such as Quanticate’s RCDM solutions represent such a fresh, holistic perspective towards tackling any future challenges faced by in the global healthcare industry.

We at GHP Magazine wish you all a Happy Christmas and New Year, and we will return in January.

GHP November 2016

GHP November 2016

Welcome to the November issue of GHP Magazine.

With 2016 drawing to a close, it is as good a time as any to reflect upon the achievements that been made, the milestones reached, and the barriers broken, in all of the facets of the ever-evolving, constantly changing medical industry.

This newest monthly issue of GHP aims to reflect in particular upon this month’s most prolific contributions to the vast field, whilst also drawing attention to the innovations on the not-too-distant horizon, that will play their part in improving healthcare and its access for people all across the world.

Of course, with new technologies becoming available almost daily, and the regular updating of practices in consequence, it might be all too easy to become lost in this quickening pace. To combat this, there are a number of firms that have made it their mission to deliver the science behind the science.

This, in particular, is the domain of Tangent90, whose Vendit program provides crucial clinical trial data in support of the global life science and healthcare sectors, in what is a highly important aspect of modern healthcare.

Other institutions, such as Amsterdam-based Scicomvisuals, have embraced and honed the capability to present detailed infographics that offer compelling breakdowns of new technologies for the benefits of generating new ideas in the process.

Healthcare, then, is a circularly flowing, constantly ebbing industry, where innovation breeds creation, resulting in a flourishing of understanding and the daring to push the boundaries even further still. The last 20 years alone have been paramount for demonstrating the versatility of modern medicine, and we at GHP aim to provide that essential gateway into the intricacies of this vast industry, to document its evolution and to help you, our readers, to stay on top of it.

Jonathan Miles, Editor

GHP October 2016

GHP October 2016

Welcome to the October edition of Global Health & Pharma, which includes the latest news, alongside a variety of exciting features, including a special guest article from the world’s first children’s hospice on why having access to palliative care is something that every person deserves.

Helen & Douglas House’s CEO Clare Periton goes on to say that advances in technology and medication have enabled drugs to be much subtler now. This progression is invaluable in the sector she believes, and is especially helpful when caring for children and young adults, as they do at Helen & Douglas House.

In addition to a major focus on health & social care, we also feature an insightful section covering innovation and technology. One contributor, Joost Bakker of Scicomvisuals, says that the biotechnology sector provides a truly dynamic environment in which goal-oriented science and bright ideas can flourish. Alongside this, he says that it takes remarkable acumen and drive to excel in this field, which is crucial to develop solutions that really help to deal with the challenges of today.

In research and development news, the Medical Research Council reveals that scientists have been able to shed more light on how the Zika virus works, by sequencing the full-length genome of the virus from a patient in Brazil and studying how a molecule derived from the genome fights the host antiviral response.

I hope that you enjoy reading this absorbing edition.

Jonathan Miles, Editor

GHP September 2016

GHP September 2016

Welcome to the September edition of Global Health & Pharma, which features a whole host of news and exciting features, including the announcement of one of the first proton beam therapy cancer treatment centres to be built in England by February 2018.

In an extended feature, Farrer Park Hospital (FPH), Singapore’s newest private healthcare service provider, provides a fascinating insight into innovation in hospital administration and incorporating the latest technology to support better decision making for better patient outcomes and shorter hospital stays.

Remaining topical and up-to-date, Elisabethann Wright of Hogan Lovells examines some of the key issues facing the pharmaceutical industry and identifies the key areas which need to be addressed as the UK progresses towards Brexit.

Looking to the future, emerging markets are the next big opportunity after the US according to Frost & Sullivan. Increased life expectancy, a growing aged population cohort, and the higher incidence of chronic lifestyle-related diseases are encouraging the use generic pharmaceuticals as governments and healthcare service providers strive to contain costs.

Ramboll’s Neil Harvey reveals that in order to meet the needs of future healthcare buildings, those who design and engineer such facilities need to think in the long term. While forecasts tell us that over the next 50 years, the number of people over 60 years of age is expected to surpass those under the age of 14, we must consider our changing needs.

I hope that you enjoy reading this packed edition

.Jonathan Miles, Editor

GHP July 2016

GHP July 2016

A very warm welcome to the July 2016 edition of Global Health & Pharma, which begins on an upbeat note with breaking health news from the UK Government, the Northern Ireland Executive, the Scottish Government and the National Assembly for Wales.

Speaking at a major conference in Cardiff, Welsh Government Cabinet Secretary for Health Vaughan Gething, recently raised awareness of the excellent employment careers that exist within NHS Wales. And Northern Ireland Health Minister Michelle O’Neill in late June set out her ambitious priorities for the next phase of reform of health and social care.

In major news, the implementation of Scotland’s £100 million cancer strategy will drive improvements in access to cancer care, Health Secretary Shona Robison said in June. The strategy will invest in the prevention, detection, diagnosis, treatment and aftercare for cancer patients – as well improving treatment waiting times.

In other news, we reveal the findings of a new report published in May, The Global Market for Population Health Management, which claims that the cumulative global economic burden of chronic disease is estimated to rise to be around US$240 trillion between 2013 and 2025. The need for solutions to the escalation in healthcare costs is being experienced within both the government and the corporate sectors in almost all countries worldwide.

Moving to the subject of technology, respected Frost & Sullivan Senior Research Analyst Tanvir Jaikishen reveals that the accelerated adoption of new technologies, therapeutic applications and innovative business models will certainly impact the European Healthcare Industry of the future.

In a special guest article, Dr Michael Sinclair and Josie Seydel, authors of the book Working with Mindfulness discuss the shift towards compassion in business, and how this can be summed up on a macro level by looking at how we can ensure that businesses are thriving rather than simply surviving. 

I hope you enjoy reading this compelling edition.

GHP April 2016

GHP April 2016

Welcome to the April 2016 edition of global health & pharma magazine, we begin the edition with a round up of news from the central government in the UK and also from Northern Ireland, Scotland and Wales. Health Minister Simon Hamilton for example recently announced a 15% increase in the annual number of pre-registration nurse training places commissioned in Northern Ireland and the establishment of a new task group on nursing.

Clare Periton is the CEO of Helen & Douglas House, the world’s first children’s hospice based in Oxford, writes about running a hospice and her thoughts on the importance of having a coordinated health and social care system.

Brother UK’s Greig Millar lifts the lid on the company’s report, ‘GP Workload: Statistics & Solutions for a More Productive Practice’, the Infographic of which highlights some of the activities that take up the most time for GPs and how technology is being used to alleviate some of that pressure.

Elsewhere, a recent report by the International Longevity Centre – UK (ILC-UK) argues that our ageing society offers significant social and economic opportunities but only if policymakers plan better for the long term.

In another piece, Leading NHS cardiologist, Dr Aseem Malhotra, in late February highlights a complete healthcare “system failure”, that is resulting in the unnecessary deaths of tens of thousands of people globally every year.

Artificial intelligence and wearables thrive across healthcare sectors, says Frost & Sullivan in an insightful article. Jyoti Nagrani, Consulting Analyst from the same company argues that the total healthcare expenditure as a percentage of gross domestic product (GDP) is expected to increase to 4.3 percent to reach $50.8 billion in 2020.

I hope you enjoy reading this compelling edition.

GHP January 2016

GHP January 2016

In an exclusive foreword, Northern Ireland Health Minister Simon Hamilton details his department’s Making Life Better Strategy which reflects the commitment of the Northern Ireland Executive to “improving health and wellbeing and reducing health inequalities, through co-ordinated and focussed action on the wider social, economic and environmental determinants of health.”

In this insightful and topical edition of global health & pharma, Professor Alan Cameron, RCOG Vice President, Clinical Quality discusses the ‘Each Baby Counts’ five-year initiative which “aims to halve the number of babies who die or are left severely disabled as a result of incidents occurring during term labour by 2020.”

Helen Donovan, Professional lead for public health nursing at the Royal College of Nursing argues that cutting public health budgets “intended to prevent health problems before they start – is incredibly short-sighted, and risky”. Dr. Bryce G. Rutter, Founder & CEO Metaphase Design Group Inc. reveals his thoughts on the dignity of living, as we continue to make incredible advances in medicine, the importance the human factor” he argues.

Other topics covered in this edition include antibiotic resistance, HIV infection and drug development. Do feel free to contact me if you would like to submit an article for the next edition or for the global health & pharma website.

“A world without antibiotics is a public health issue and avoiding the apocaplypse needs the public interest at its heart.”

GHP December 2015

GHP December 2015

Welcome to the December Issue of ghp Magazine.

As 2015 draws to a close Nooman Haque, Director of Healthcare & Life Sciences for the Silicon Valley Bank UK Branch talks us through the prevalent trends in the healthcare sector over the past year.

This issue’s foreword comes from Northern Ireland’s Health Minister, Simon Hamilton, who provides us with an insight into his department’s latest initiative, Making Life Better.

Guy’s and St Thomas’ infrastructure department also offers outsourced services to firms and other NHS trusts. We speak to Tracy Cheung, Head of Marketing and Engagement, and Anne-Marie Watts, Head of Sterile Services, to gain a fascinating insight into the firm and its work.

Mark Britnell talks us through his innovative new book, In Search of a Perfect Health System, which offers a global analysis of healthcare services from around the world and the positive and negative aspects of each.

In this issue we also explore a number of exciting new strategies from Public Health England, which could change the face of the UK health service in the long run.

We hope you enjoy this issue.

GHP October 2015

GHP October 2015

Welcome to the October issue of ghp Magazine.

This month, Tony Hughes, CEO of Huthwaite International, explains the Urgo Medical’s revolutionary new sales in healthcare technique.

Richard McCann meets Queen Alexandra Hospital’s Colin Walker and explores how their wireless monitoring and data recording technology is changing the way their pathology department works for the better.

We put the spotlight on the UK health service, showcasing a number of new schemes from Public Health England, Monitor and the NHS.

Recruiters are put under the spotlight as we explore what it means to be audit ready and if firms are doing enough.

Trends in the global healthcare market are outlined by Nooman Haque, Director of Healthcare & Life Sciences for the Silicon Valley Bank UK Branch.

Managing the care of serious brain injuries can be a difficult task, but as we show you, a new partnership between Philips and the Massachusetts Institute of Technology could be about to change that.

We hope you enjoy this issue.

GHP September 2015

GHP September 2015

Welcome to the September Edition of GHP Magazine.

This edition we spotlight addiction, examining Alcohol Related Brain Damage from David Swain at Pulse Addictions, as well as examining the Telford After Care Team and the work they are doing to change the way addiction is treated in the area.

Funding in healthcare is another area of focus, with Silicon Valley Bank examining global trends in healthcare investment. We also look into the future trends in M&A transactions in the health and pharma industries, analysing new data from Baker & McKenzie which shows an increase in this area over the next five years.

Dr. Sue Paterson and Joan Kingsley exploring bullying in the NHS, from how it affects victims and their work to how it can be dealt with effectively.

Exciting new technology is ingratiating into the industry, with new blood pressure monitors set to change management of bloody pressure issues for the better, while Farzad Henareh looks into health technology apps and the changes these are bringing about to regulation in the industry.

Lisa Lundgren and Gustav Söderlund from Norrbotten County Council explore the topic of e-health in the remote Swedish county and how it is changing the lives of the elderly population.

We hope you enjoy this issue.

GHP August 2015

GHP August 2015

Welcome to the August edition of GHP magazine.

This month the JPIAMR discusses antimicrobial resistance and what needs to be done to overcome it.

Glen Hodgson, Head of Healthcare at GS1 UK talks us through how the not-for-profit organisation is changing the NHS for the better.

On the topic of the NHS, the King’s fund explain the policy commitments due to take place within the service by 2020.

Anoto digital pens are in the spotlight this month, with the Welsh Ambulance Services NHS Trust discussing how the technology fits into their modernisation plans and Anoto themselves explaining how the pens work and what they can do for healthcare services.

Paul Klein Breteler runs over the benefits of MSM and its potential uses in healthcare.

Also in this month’s edition Sarah Waller highlights the importance of designing safe environments for dementia patients.

Small pharma is the place to be, according to Abid Kanji, who outlines the benefits of smaller firms in the industry.

The disguised threat of Bacterial vaginosis is explored in detail as Laccure showcase a new product designed to prevent and cure it. 

We hope you enjoy the issue.

GHP July 2015

GHP July 2015

Welcome to the July Issue of GHP Magazine.

This month we have a speech by Gabriel Wikström, the Swedish Minister for Health, discussing antimicrobial resistance and the Swedish government’s actions against it.

We also take a look at the Nordic Life Science days, a global event bringing together leaders in the global life science industry.

Focusing on diabetes, we pinpoint a clinical trial which shows the benefits of Biocool, a foot bath product, for treating foot issues often prevalent among diabetes sufferers.

Innovative new treatment for tendinopathy is analysed this month as we examine the potential effects that CollPlant’s new product could have on healthcare.

We turn the spotlight on the NHS, examining a new Healthwatch report which shows that the discharge procedures within the service need drastic remodelling.There is also a report about the drop in organ donation and the effect this is having on an already strained service.

There is also a piece about how a potential British exit from the Euro could affect the life sciences industry and we have an exclusive interview with Dr Rossant of the Ontario Institute for Regenerative Medicine, who outlines the effects that new government funding will have on the research being done at the institute.

We hope you enjoy this issue!